New genetic cause of children's liver disease discovered

March 11, 2014
New genetic cause of children's liver disease discovered

(Medical Xpress)—The discovery of a 'faulty gene' in children with liver disease could pave the way for new treatments for children with a range of serious and life-threatening liver conditions.

The findings – published on Sunday, 9 March in Nature Genetics – follow two years of research by doctors and scientists at King's College London and King's College Hospital, both part of King's Health Partners AHSC.

Cholestatic liver disease (CLD) describes a number of conditions caused by impairment of bile formation, or bile flow. Normal bile production is essential for absorption of food and the body's ability to dispose of waste. CLD can be fatal, and many patients require . At least 12,000 people suffer from CLD in the UK.

Using the latest gene sequencing technology, the team at King's discovered that 12 patients with CLD had a mutation in both copies of the TJP2 gene, which means it doesn't produce the TJP2 protein.

This discovery of a new disease, called 'TJP2 deficiency', is a significant breakthrough. Crucially, it now means liver experts understand the mechanism underlying the disease, and can start treatment earlier and in a targeted fashion.

Dr Richard Thompson, a paediatric liver specialist at King's who led the research, said the findings should increase our understanding of the way other types of liver disease develop. He said:

'This is extremely exciting. By understanding the disease better, we are a step closer to one day finding a cure. In the short-term, it also makes the disease much easier to diagnose –we have gone from basic science discovery to routine diagnostic testing in less than a year, which is amazing. Crucially, this means we can start logical treatment for the disease sooner. The basic principles of the discovery could also be applied to other, more common forms of liver disease, which is also very exciting.'

King's, a major centre for the treatment of adult and paediatric , is one of three centres currently trialling a new drug for the treatment for CLD in children.

Explore further: NSAID use linked to reduced hepatocellular carcinoma risk and mortality due to chronic liver disease

More information: "Mutations in TJP2 cause progressive cholestatic liver disease." Melissa Sambrotta, et al. Nature Genetics (2014) DOI: 10.1038/ng.2918. Received 21 September 2013 Accepted 14 February 2014 Published online 09 March 2014

Related Stories

British team perform new 'warm' liver transplants

March 15, 2013

British surgeons said Friday they have performed successful liver transplants on two patients using a revolutionary technique which keeps the organ warm and functioning while outside the body.

FDA reports Samsca may cause liver damage

May 2, 2013

(HealthDay)—After reviewing data from recent large clinical trials, the U.S. Food and Drug Administration has determined that Samsca (tolvaptan) should not be used for longer than 30 days and should not be used at all by ...

Mini-livers show promise to reduce animal use in science

February 26, 2014

Research that has for the first time successfully grown "mini-livers" from adult mouse stem cells has won the UK's international prize for the scientific and technological advance with the most potential to replace, reduce ...

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...

Molecular clocks control mutation rate in human cells

November 9, 2015

Every cell in the human body contains a copy of the human genome. Through the course of a lifetime all cells are thought to acquire mutations in their genomes. Some of the mutational processes generating these mutations do ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.